| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(83)80338-6 |
| P698 | PubMed publication ID | 6685151 |
| P2093 | author name string | J A Werner | |
| H L Greene | |||
| P J Kudenchuk | |||
| G B Trobaugh | |||
| B W Gross | |||
| G K Sears | |||
| E L Graham | |||
| J P Gorham | |||
| P2860 | cites work | ??? | Q64869077 |
| Clinical efficacy of amiodarone as an antiarrhythmic agent | Q28329369 | ||
| Amiodarone-induced polymorphous ventricular tachycardia | Q33172968 | ||
| Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide | Q33173087 | ||
| Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias | Q33173226 | ||
| Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones | Q34316851 | ||
| Dangers of amiodarone and anticoagulant treatment | Q34780234 | ||
| Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias | Q36773927 | ||
| Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone | Q40302111 | ||
| Amiodarone increases plasma digoxin concentrations | Q41714699 | ||
| Amiodarone keratopathy: drug-induced lipid storage disease | Q41925487 | ||
| Dangerous interaction between amiodarone and quinidine | Q42241568 | ||
| Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients | Q42245850 | ||
| Amiodarone in refractory life-threatening ventricular arrhythmias | Q42259478 | ||
| Amiodarone-induced ventricular tachycardia | Q42265133 | ||
| Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone | Q43857291 | ||
| Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone | Q44255254 | ||
| Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. | Q50937859 | ||
| Side effects of long-term amiodarone therapy | Q67233122 | ||
| Letter: Amiodarone and neurological side-effects | Q70011945 | ||
| Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug | Q70283555 | ||
| The potentiation of warfarin anticoagulation by amiodarone | Q70333449 | ||
| Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy | Q70367697 | ||
| Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia | Q70424322 | ||
| Amiodarone--benefits and risks in perspective | Q70501449 | ||
| Amiodarone pulmonary toxicity | Q70535120 | ||
| Possible amiodarone-aprindine interaction | Q70679293 | ||
| Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias | Q71024651 | ||
| Possible association of pneumonitis with amiodarone therapy | Q71286568 | ||
| Interaction between warfarin sodium and amiodarone | Q71447132 | ||
| Ventricular flutter during treatment with amiodarone | Q71657550 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amiodarone | Q410061 |
| P304 | page(s) | 1114-1128 | |
| P577 | publication date | 1983-12-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias | |
| P478 | volume | 2 |
| Q22306346 | 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration |
| Q30985909 | A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data. |
| Q40745450 | A consensus report on antiarrhythmic drug use. |
| Q83150391 | A randomized trial of budiodarone in paroxysmal atrial fibrillation |
| Q22306349 | ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...] |
| Q69990657 | Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction |
| Q38682721 | Adverse effects of amiodarone. Pathogenesis, incidence and management |
| Q70797956 | Amiodarone for long-term management of patients with hypertrophic cardiomyopathy |
| Q69737532 | Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients |
| Q36660391 | Amiodarone in Long Term Prophylaxis |
| Q39631851 | Amiodarone in the management of cardiac arrhythmias: current concepts |
| Q69960734 | Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy |
| Q68960477 | Amiodarone lung: pathologic findings in clinically toxic patients |
| Q68469412 | Amiodarone pulmonary toxicity: Prospective evaluation of serial pulmonary function tests |
| Q54487002 | Amiodarone pulmonary toxicity: early changes in pulmonary function tests during amiodarone rechallenge. |
| Q54468030 | Amiodarone treatment of critical arrhythmias in children and young adults. |
| Q42519901 | Amiodarone-induced keratopathy in healthy dogs |
| Q51737485 | Amiodarone: A Newly Discovered Association with Bilateral Vestibulopathy. |
| Q68965660 | Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias |
| Q40172905 | Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects |
| Q36063724 | Anti-arrhythmic medications increase non-cardiac mortality - A meta-analysis of randomized control trials |
| Q36663794 | Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance |
| Q40572178 | Asymptomatic cavitary pneumonitis due to amiodarone pulmonary toxicity |
| Q37223776 | Ataxia: a diagnostic perplexity and management dilemma |
| Q45104281 | Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study |
| Q68696101 | Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients |
| Q57780462 | Bronquiolitis obliterante con neumonía organizativa focal y amiodarona |
| Q38642055 | Cardiac arrhythmias: the role of pharmacologic intervention. |
| Q33825602 | Cardiac involvement with parasitic infections |
| Q35994626 | Class III drugs: their effects on arrhythmias and on the QT interval |
| Q40190296 | Clinical use and pharmacology of amiodarone |
| Q34118183 | Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure |
| Q38023577 | Comparative hemodynamics of antiarrhythmic drugs |
| Q44415897 | Comparison of survival of amiodarone-treated patients with coronary artery disease and malignant ventricular arrhythmias with that of a control group with coronary artery disease |
| Q33948079 | Confocal laser-scanning microscopy allows differentiation between Fabry disease and amiodarone-induced keratopathy |
| Q40601626 | Cost-effectiveness analysis in heart disease, Part III: Ischemia, congestive heart failure, and arrhythmias |
| Q44921438 | Detection of amiodarone pulmonary toxicity: To screen or not to screen, that is the question! |
| Q30445158 | Diagnosis and management of epididymitis |
| Q40490665 | Drug effects on the electrocardiogram. A review of their clinical importance |
| Q38267726 | Drug-induced cerebellar ataxia: a systematic review |
| Q70696132 | Effect of amiodarone on ventricular function as measured by gated radionuclide angiography |
| Q40484997 | Electrophysiologic testing: predictive of amiodarone efficacy in recurrent sustained ventricular tachycardia? |
| Q24530191 | Epididymitis caused by treatment with amiodarone |
| Q37578338 | Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay |
| Q68146277 | Hemodynamic effects of amiodarone during acute and chronic treatment in patients with recurrent sustained ventricular tachycardia Received: August 14, 1991 |
| Q69643769 | High-performance liquid chromatographic analysis of amiodarone and desethylamiodarone in serum |
| Q43646097 | Increased cardiac alpha-1-adrenoceptor density in rats following treatment with amiodarone |
| Q74152373 | Is there a common mechanism of benefit for effective treatment of heart failure? |
| Q73213127 | Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety |
| Q94527292 | Low-dose Amiodarone Is Safe: A Systematic Review and Meta-analysis |
| Q71095732 | Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy |
| Q40681386 | New antiarrhythmic drugs in pediatric use: amiodarone |
| Q51782188 | New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone. |
| Q72593706 | Non-infectious epididymitis associated with amiodarone therapy |
| Q41716844 | Ocular side effects of amiodarone |
| Q34353550 | Phenomenology and treatment of tremor disorders |
| Q34447676 | Plasma amiodarone concentrations during intravenous infusion |
| Q35864997 | Predictors of the risk of falls among elderly with chronic atrial fibrillation |
| Q35214792 | Regulation and critical role of potassium homeostasis in apoptosis |
| Q68994103 | Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity |
| Q34727690 | Segmental pulmonary consolidation due to amiodarone. |
| Q42720514 | Severe muscle cramps after intravenous administration of amiodarone--a novel, potentially dose-dependent adverse effect |
| Q33581362 | Sudden cardiac death--a perspective |
| Q46448157 | Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts |
| Q36038058 | Ultrastructural Changes in Rat's Atrial Cardiomyocytes After Short Term Administration of Amiodarone and Possible Protective Role of Vitamin E. |
| Q51138296 | Unilateral amiodarone keratopathy: occlusive contact lens spares development in the contralateral eye. |
| Q68339288 | Use dependence of amiodarone during the sinus tachycardia of exercise in coronary artery disease |
| Q43925050 | Visual functions and adverse ocular effects in patients with amiodarone medication |
| Q42214578 | Worsening of ventricular tachycardia by amiodarone |
Search more.